Discover NOVAptamers: Highly Specific Aptamers for Your Projects
Our R&D team is proud to introduce NOVAptamers – a range of aptamers developed and optimized by Novaptech – designed against a wide variety of targets, including proteins, peptides and small molecules. 🧬 Browse our NOVAptamers collection today and find the one that fits your needs! Test them today in your lab – whether you’re working in fundamental research, diagnostics, or biotechnology – NOVAptamers are the solution to accelerate your developments. Customizable with various functional groups, they integrate easily into your assay or device. New NOVAptamers targeting small molecules, pesticides, antibiotics, and peptides will be added soon. Stay connected!! Feel free to contact us for advice and for a personalized offer or pricing information. Explore our solutions now!
Novaptech at the Biacore™ Users Meeting 2025 in Lyon on June 25th
We’re pleased to announce that Novaptech will participate in the French Biacore™ User Meeting, organized by Cytiva. Dr. Petra Ivaskovic, SPR (Surface Plasmon Resonance) and BLI (BioLayer Interferometry) specialist at Novaptech, will present our work on aptamer/ target complexes using a SPR Biacore™ T200 instrument. Examples will be described for small molecule, peptide and protein interactions with our in house-selected and optimized NOVAptamers. Dr. Ivaskovic will be available on-site for discussions. Don’t hesitate to book a slot and connect with her during the event — it’s a great opportunity to talk about NOVAptamers applications and explore how they could address your specific needs. See you there! For booking a slot with Petra and more information, feel free to contact us at contact@novaptech.com or LinkedIn.
Novaptech: new offices!
Inauguration of the brand new premises of Novaptech, a leading biotechnology company producing aptamers for the detection of contaminants in the food industry Novaptech, an innovative biotechnology company, inaugurated its new premises in Gradignan on May 31st, 2024, in the presence of Mr Alain Rousset, President of the Conseil RĂ©gional de Nouvelle-Aquitaine. Created in 2016 from Jean-Jacques ToulmĂ©’s academic laboratory at the University of Bordeaux, Novaptech currently has 9 employees and plans to recruit a further 5 by the end of 2025. Specialising in the development of aptamers, Novaptech stands out as the only French company to master this breakthrough technology. Aptamers, which can replace antibodies in all analytical, diagnostic and therapeutic applications, are at the heart of Novaptech’s strategy. The company is initially focusing on the development of biosensors for real-time detection of contaminants in the agri-food industry, such as pesticides, micropollutants and endocrine disruptors, in response to the need for rapid, simple and decentralised testing. In line with the objectives of the Neo Terra strategic roadmap drawn up by the Conseil RĂ©gional de Nouvelle-Aquitaine for the ecological and energy transition, Novaptech recently validated its first laboratory-scale aptasensor. The Conseil RĂ©gional de Nouvelle-Aquitaine has supported Novaptech since its creation. Once again this year, the Region has supported the company in strengthening its export strategy, particularly in Asia. The inauguration of these brand new premises marks an important step for Novaptech, consolidating its role as a leader in the biotechnology sector and its commitment to innovation and the protection of public health. For more details, read the full press release from the Cabinet of President Alain Rousset here (in French).
ECHOS is talking about us!
ECHOS is talking about us ! https://www.echos-judiciaires.com/actualites/novaptech-le-potentiel-insoupconne-des-aptameres/Â
EN 
FR